- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04493372
Deciphering Preserved Autonomic Function After Spinal Cord Injury
February 9, 2024 updated by: Ryan J. Solinsky, Mayo Clinic
This study looks to characterize gradients of dysfunction in the autonomic nervous system after spinal cord injury.
The autonomic nervous system plays key roles in regulation of blood pressure, skin blood flow, and bladder health- all issues that individuals with spinal cord injury typically suffer.
Focusing on blood pressure regulation, the most precise metric with broad clinical applicability, the investigators will perform laboratory-based tests to probe the body's ability to generate autonomic responses.
For both individuals with spinal cord injury and uninjured controls, laboratory-based experiments will utilize multiple parallel recordings to identify how the autonomic nervous system is able to inhibit and activate signals.
The investigators anticipate that those with autonomic dysfunction after spinal cord injury will exhibit abnormalities in these precise metrics.
The investigators will further have research participants wear a smart watch that tracks skin electrical conductance, heart rate, and skin temperature, which can all provide clues as to the degree of autonomic dysfunction someone may suffer at home.
The investigators will look to see if any substantial connections exist between different degrees of preserved autonomic function and secondary autonomic complications from spinal cord injury.
In accomplishing this, the investigators hope to give scientists important insights to how the autonomic nervous system works after spinal cord injury and give physicians better tools to manage these secondary autonomic complications.
Study Overview
Status
Suspended
Detailed Description
This study looks to characterize gradients of dysfunction in the autonomic nervous system after spinal cord injury.
To accomplish this, we are enrolling both individuals with and without spinal cord injuries (see inclusion criteria).
Individuals will undergo the listed diagnostics as part of a battery of laboratory testing.
These will be correlated to clinical histories of autonomic dysfunction the ADFSCI and COMPASS-31 surveys (noted in outcome measures).
Study Type
Interventional
Enrollment (Estimated)
69
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55902
- Mayo Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
All subjects
- age 18-50 years old.
Participants with spinal cord injury
- Adult onset, traumatic spinal cord injury.
- American Spinal Injury Association Impairment Scale, A-D, to encompass a spectrum of autonomic dysfunction after spinal cord injury.
- Neurological level of injury, C1-T12, as defined by the International Standards for Neurological Classification of Spinal Cord Injury. Incorporating level of injury down to T12 to encompass a broad range of autonomic dysfunction.
Exclusion Criteria:
- History of cardiovascular disease, hypertension, neurologic disorders (with exception of spinal cord injury), or diabetes.
- Women who are pregnant or lactating.
- Currently taking blood thinners.
- Pacemaker, implanted defibrillator, or intrathecal pump incompatible with MRI scanning.
- Cognitive issues preventing informed consent for participation.
- Body mass index >30 kg/m2 for controls, in an effort to limit effects of early cardiovascular disease and diabetes in control population. Body mass index has not proven to be a good estimate of these factors following spinal cord injury.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Individuals with spinal cord injury
|
Bolus phenylephrine infusion using the Oxford technique will generate the need to inhibit sympathetic activity.
Similarly, resting state Mayer waves will be assessed with regard to heart rate and blood pressure responses.
Cold pressor test of the hand will be used to cause sympathetic activation.
Valsalva's maneuver will assess the ability to buffer against blood pressure fall (phase II).
Cold pressor test of the foot and bladder pressor response (in individuals with SCI) will be tested.
|
Experimental: Individuals without spinal cord injury
|
Bolus phenylephrine infusion using the Oxford technique will generate the need to inhibit sympathetic activity.
Similarly, resting state Mayer waves will be assessed with regard to heart rate and blood pressure responses.
Cold pressor test of the hand will be used to cause sympathetic activation.
Valsalva's maneuver will assess the ability to buffer against blood pressure fall (phase II).
Cold pressor test of the foot and bladder pressor response (in individuals with SCI) will be tested.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Valsalva Maneuver Phase II
Time Frame: During laboratory diagnostic testing session
|
Presence or absence of phase II on Valsalva maneuver testing, which takes approximately 15 seconds to complete.
This will be repeated x3.
|
During laboratory diagnostic testing session
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Beat-to-beat heart rate
Time Frame: During laboratory diagnostic testing session
|
Electrocardiogram will record continuous measures with changes in R-R interval (ms) quantified and compared to baseline.
|
During laboratory diagnostic testing session
|
Beat-to-beat blood pressure
Time Frame: During laboratory diagnostic testing session
|
Non-invasive continuous blood pressure monitors will be used, with changes in systolic and diastolic pressure (in mmHg) from resting baseline measured.
|
During laboratory diagnostic testing session
|
Continuous galvanic skin response
Time Frame: During laboratory diagnostic testing session
|
Changes from resting state conductance with be quantified with a smartwatch.
|
During laboratory diagnostic testing session
|
Continuous wrist temperature
Time Frame: During laboratory diagnostic testing session
|
Changes from resting state temperature with be quantified with a smartwatch.
|
During laboratory diagnostic testing session
|
Quantify autonomic dysreflexia and orthostatic hypotension
Time Frame: Baseline, prior to laboratory diagnostic testing session
|
Participants will be given the Autonomic Dysfunction Following Spinal Cord Injury questionnaire (score range 0-436, with higher scores indicating more autonomic dysfunction).
|
Baseline, prior to laboratory diagnostic testing session
|
Quantify secondary autonomic complications
Time Frame: Baseline, prior to laboratory diagnostic testing session
|
Participants will be given the Composite Autonomic Symptom Score (range 0-100, with higher scores indicating more autonomic dysfunction).
|
Baseline, prior to laboratory diagnostic testing session
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ryan Solinsky, MD, Mayo Clinic
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 13, 2020
Primary Completion (Estimated)
December 1, 2024
Study Completion (Estimated)
December 1, 2024
Study Registration Dates
First Submitted
July 17, 2020
First Submitted That Met QC Criteria
July 28, 2020
First Posted (Actual)
July 30, 2020
Study Record Updates
Last Update Posted (Estimated)
February 13, 2024
Last Update Submitted That Met QC Criteria
February 9, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Cardiovascular Diseases
- Vascular Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Trauma, Nervous System
- Spinal Cord Diseases
- Autonomic Nervous System Diseases
- Primary Dysautonomias
- Orthostatic Intolerance
- Wounds and Injuries
- Hypotension
- Spinal Cord Injuries
- Hypotension, Orthostatic
- Autonomic Dysreflexia
Other Study ID Numbers
- 23-005772
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spinal Cord Injuries
-
Khon Kaen UniversityUnknownInjuries, Spinal Cord
-
Universidade do Vale do ParaíbaCompletedInjuries, Spinal Cord
-
InVivo TherapeuticsTerminated
-
Ekso BionicsBurke Medical Research InstituteCompletedInjuries, Spinal CordUnited States
-
ReWalk Robotics, Inc.Unknown
-
Shepherd Center, Atlanta GACompletedInjuries, Spinal Cord
-
Wroclaw Medical UniversityInstitute of Immunology and Experimental Therapy of the Polish Academy of... and other collaboratorsUnknownComplete Spinal Cord InjuriesPoland
-
M.D. Anderson Cancer CenterActive, not recruitingMetastatic Epidural Spinal Cord CompressionUnited States
Clinical Trials on Tests of sympathetic inhibition
-
Spaulding Rehabilitation HospitalMedical University of South CarolinaCompletedSpinal Cord Injuries | Autonomic Dysreflexia | Autonomic Imbalance | Orthostatic; Hypotension, NeurogenicUnited States
-
University of MinnesotaRecruitingHypertension | Menopause | Blood Pressure | Menopause, PrematureUnited States
-
Université Catholique de LouvainErasme University HospitalUnknownHeart Rate Variability | Autonomic Nervous System | Muscle Sympathetic Nerve ActivityBelgium
-
Cindy HallWithdrawnSudden Cardiac DeathAustralia
-
Seoul National UniversityUnknownComplex Regional Pain Syndrome | Peripheral Neuropathy | Diabetic Polyneuropathy | Postherpetic NeuralgiaKorea, Republic of
-
Tomsk National Research Medical Center of the Russian...CompletedChronic Heart FailureRussian Federation
-
McMaster UniversityCanadian Institutes of Health Research (CIHR); The Physicians' Services Incorporated...RecruitingCOVID-19 | GastroIntestinal BleedingCanada
-
University of PecsUnknownPerioperative/Postoperative Complications | Abdominal Aortic Aneurism | Abdominal Aortic Rupture | Surgical Blood Loss
-
University of Maryland, College ParkVanderbilt University; National Institute on Deafness and Other Communication...Enrolling by invitationAging | Hearing Loss | Hearing Loss, Sensorineural | Cochlear Hearing LossUnited States